PLoS ONE (Jan 2013)

Dopaminergic neuronal imaging in genetic Parkinson's disease: insights into pathogenesis.

  • Alisdair McNeill,
  • Ruey-Meei Wu,
  • Kai-Yuan Tzen,
  • Patricia C Aguiar,
  • Jose M Arbelo,
  • Paolo Barone,
  • Kailash Bhatia,
  • Orlando Barsottini,
  • Vincenzo Bonifati,
  • Sevasti Bostantjopoulou,
  • Rodrigo Bressan,
  • Giovanni Cossu,
  • Pietro Cortelli,
  • Andre Felicio,
  • Henrique B Ferraz,
  • Joanna Herrera,
  • Henry Houlden,
  • Marcelo Hoexter,
  • Concepcion Isla,
  • Andrew Lees,
  • Oswaldo Lorenzo-Betancor,
  • Niccolo E Mencacci,
  • Pau Pastor,
  • Sabina Pappata,
  • Maria Teresa Pellecchia,
  • Laura Silveria-Moriyama,
  • Andrea Varrone,
  • Tom Foltynie,
  • Anthony H V Schapira

DOI
https://doi.org/10.1371/journal.pone.0069190
Journal volume & issue
Vol. 8, no. 7
p. e69190

Abstract

Read online

To compare the dopaminergic neuronal imaging features of different subtypes of genetic Parkinson's Disease.A retrospective study of genetic Parkinson's diseases cases in which DaTSCAN (123I-FP-CIT) had been performed. Specific non-displaceable binding was calculated for bilateral caudate and putamen for each case. The right:left asymmetry index and striatal asymmetry index was calculated.Scans were available from 37 cases of monogenetic Parkinson's disease (7 glucocerebrosidase (GBA) mutations, 8 alpha-synuclein, 3 LRRK2, 7 PINK1, 12 Parkin). The asymmetry of radioligand uptake for Parkinson's disease with GBA or LRRK2 mutations was greater than that for Parkinson's disease with alpha synuclein, PINK1 or Parkin mutations.The asymmetry of radioligand uptake in Parkinsons disease associated with GBA or LRRK2 mutations suggests that interactions with additional genetic or environmental factors may be associated with dopaminergic neuronal loss.